0000899243-18-028722.txt : 20181113 0000899243-18-028722.hdr.sgml : 20181113 20181113163303 ACCESSION NUMBER: 0000899243-18-028722 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181108 FILED AS OF DATE: 20181113 DATE AS OF CHANGE: 20181113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pourhassan Nader CENTRAL INDEX KEY: 0001532878 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 181178455 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-11-08 0 0001175680 CytoDyn Inc. CYDY 0001532878 Pourhassan Nader 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 1 1 0 0 President and CEO Stock Options (right to buy) 0.565 2018-11-08 4 A 0 1000000 0.00 A 2028-11-08 Common Stock 1000000 1000000 D Fifty percent (50%) of the options were fully vested and exercisable as of the date of the reported transaction, and fifty percent (50%) of the options will vest on April 8, 2019. /s/ Michael D. Mulholland, as attorney-in-fact 2018-11-13